These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions. Lehman JS, Kalaaji AN. J Am Acad Dermatol; 2010 Nov; 63(5):815-23. PubMed ID: 20643496 [Abstract] [Full Text] [Related]
6. Pneumocystis pneumonia in patients with immunobullous dermatoses. Li F, Jin HZ, Su F, Jia L, Sun QN. Int J Dermatol; 2011 Sep; 50(9):1144-9. PubMed ID: 22126881 [Abstract] [Full Text] [Related]
7. Pneumocystis carinii pneumonia among patients with neoplastic disease. Sepkowitz KA. Semin Respir Infect; 1992 Jun; 7(2):114-21. PubMed ID: 1439321 [Abstract] [Full Text] [Related]
14. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arend SM, Kroon FP, van't Wout JW. Arch Intern Med; 2003 Jul; 155(22):2436-41. PubMed ID: 7503602 [Abstract] [Full Text] [Related]
15. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, De Gentile L, Gandji JA, Guimard Y, Lacroix C, Roblot P, Becq-Giraudon B. Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):523-31. PubMed ID: 12172743 [Abstract] [Full Text] [Related]